Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why MacroGenics Stock Popped Again Today


Not to jinx it, but MacroGenics (NASDAQ: MGNX) might just be at the start of a winning streak. For the second straight day, powered by very encouraging quarterly results, the biotech's shares saw a notable rise on Monday. The stock gained more than 8% on the day as yet another analyst weighed in with a post-earnings price target raise.

Monday's price target lifter was H.C. Wainwright's Debjit Chattopadhyay, who now feels MacroGenics is worth $12 per share, up from his previous $11. He maintained a buy recommendation on the stock.

That was the third price target boost across the past two trading days.

Continue reading


Source Fool.com

Like: 0
Share

Comments